Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
That breakthrough led to SHIELD, the first FDA-approved blood test for colon cancer, cleared in 2024. The test is ...
The Galleri multi-cancer early detection (MCED) test – which looks for around 50 different types – achieved a seven-fold increase in cancer detection when added to standard screening tests for breast, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback